With the right treatment, the time to face up to the bumps and blemishes of your rosacea is now. No matter where you are on your rosacea journey, going to a dermatologist can help get your treatment on track
Sign up to receive email and video resources, including skincare tips, lifestyle hacks, and advice on partnering with your dermatologist to help you manage the bumps and blemishes of your rosacea. Start receiving your rosacea insights today
Starting a conversation with your dermatologist and getting a tailor-made treatment plan that is right for you is the first step in helping to get the bumps and blemishes of your rosacea under control
By telling your dermatologist how you are feeling, they can better understand how rosacea is impacting you, both physically and emotionally. The time to face up to rosacea is now!
As you’ve chosen to opt-out, you will no longer receive updates from ORACEA® (doxycycline, USP) 40 mg* Capsules
If you would like to sign up again in the future, please visit oracea.com/hcp We hope to see you again soon!
Indication: ORACEA® (doxycycline, USP) 40 mg* Capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established
You are encouraged to report negative side effects of prescription drugs to the FDA
Visit www.fda.gov/medwatch or call 1-800-FDA-1088
*30 mg immediate release and 10 mg delayed release beads